Irish medical device firm Neuromod scores Series B

Neuromod, an Irish medical device company specializing in the treatment of tinnitus, has raised 10.5 million euros in Series B financing.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this